The challenge of methicillin resistant staphylococcal infection after total hip replacement: Overlooked or overstated?

Bone and Joint Journal

Volumn 96B, Issue 11, 2014, Pages 60-65

  Parry, M C ^a   Duncan, C P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; DEBRIDEMENT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PERIPROSTHETIC JOINT INFECTION; TOTAL HIP PROSTHESIS; HEALTH; HIP ARTHROPLASTY; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; GLOBAL HEALTH; HUMANS; INCIDENCE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 84919614682     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.96B11.34333     Document Type: Article

References (79)

1. Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster J-Y. Health-related quality of life in total hip and total knee arthroplasty: a qualitative and systematic review of the literature. J Bone Joint Surg [Am] 2004;86-A:963-974.
2. Daigle ME, Weinstein AM, Katz JN, Losina E. The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. Best Pract Res Clin Rheumatol 2012;26:649-658.
3. Chang RW. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996;275:858.
4. Matthews PC, Berendt AR, McNally MA, Byren I. Diagnosis and management of prosthetic joint infection. BMJ 2009;338:1773.
5. Berend KR, Lombardi AV, Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 2012;471:510-518.
6. Beswick AD, Elvers KT, Smith AJ, et al. What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients. BMC Medicine 2012;10:18-28.
7. Sanzên L, Carlsson AS, Josefsson G, Lindberg LT. Revision operations on infected total hip arthroplasties: two- to nine-year follow-up study. Clin Orthop Relat Res 1988;229:165-172.
8. Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Ortho 2010;35:253-260.
9. Lange J, Troelsen A, Thomsen R, Soballe. Chronic infections in hip arthroplasties: Comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis. Clin Epidem 2012;4:57-73.
10. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg [Br] 2003;85-B:637-640.
11. Luu A, Syed F, Raman G, et al. Two-stage arthroplasty for prosthetic joint infection: A systematic review of acute kidney injury, systemic toxicity and infection control. J Arthroplasty 2013;28:1490-1498.
12. Bozic KJ. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg [Am] 2005;87-A:1746-1751.
13. Gehrke T, Kendoff D. Peri-prosthetic hip infections: In favour of one-stage. Hip Int 2012;22:40-45.
14. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: A cost analysis approach. Orthop Traumatol Surg Res 2010;96:124-132.
15. Klouche S, Leonard P, Zeller V, et al. Infected total hip arthroplasty revision: Oneor two-stage procedure? Orthop and Trauma: Surg and Res 2012;98:144-150.
16. Merollini KM, Crawford RW. Surgical treatment approaches and reimbursement costs of surgical site infections post hip arthroplasty in Australia: a retrospective analysis. BMC Helath Serv Res 2013;13:91-98.
17. Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection. J Bone Joint Surg [Am] 2011;93-A:631-639.
18. Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg [Br] 2008;90-B:1580-1584.
19. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-1654.
20. Leonard HAC, Liddle AD, Burke Ó, Murray DW, Pandit H. Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature. Clin Orthop Relat Res 2013;472:1036-1042.
21. Koyonos L, Zmistowski B, Valle Della CJ, Parvizi J. Infection control rate of irrigation and débridement for periprosthetic joint infection. Clin Orthop Relat Res 2011;469:3043-3048.
22. Odum SM, Fehring TK, Lombardi AV, et al. Irrigation and debridement for periprosthetic infections. J Arthroplasty 2011;26:114-118.
23. Sherrell JC, Fehring TK, Odum S, et al. The Chitranjan Ranawat Award: Fate of two-stage reimplantation after failed irrigation and débridement for periprosthetic knee infection. Clin Orthop Relat Res 2010;469:18-25.
24. Hansen E, Tetreault M, Zmistowski B, et al. Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection. Clin Orthop Relat Res 2013;471:3214-3222.
25. Bori G, Muñoz-Mahamud E, Cuñé J, et al. One-stage revision arthroplasty using cementless stem for infected hip arthroplasties. J Arthroplasty 2014;29:1076-1081.
26. Choi HR, Kwon YM, Freiberg AA, Malchau H. Comparison of one-stage revision with antibiotic cement versus two-stage revision results for infected total hip arthroplasty. J Arthroplasty 2013;28:66-70.
27. Parvizi J, Gehrke T. Proceedings of the international consensus meeting on periprosthetic joint infection. J Orthop Res 2013;32:S1-S172.
28. Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28:1047-1053.
29. Parvizi J, Ghanem E, Azzam KA, et al. Periprosthetic infection: are current treatment strategies adequate? Acta Orthop Belg 2008;74:793-800.
30. Fulkerson E, Valle CJ, Wise B, et al. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg [Am] 2006;88-A:1231-1237.
31. Ip D, Yam SK, Chen CK. Implications of the changing pattern of bacterial infections following total joint replacements. J Orthop Surg (Hong Kong) 2005;13:125-130.
32. DeLeo FR, Otto M, Kreiswirth BN. Community-associated methicillin resistant Staphylococcus aureus. Lancet 2010;375:1557-1568.
33. Goyal N, Miller A, Tripathi M, Parvizi J. Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 2013;95-B:4-9.
34. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003;9:978-984.
35. Kocsis E, Kristof K, Hermann P, Rozgonyi F. A comparative review on the pathogenicity and virulence factors of methicillin resistant and methicillin susceptible Staphylococcus aureus. Rev Med Microbiol 2010;21:31-37.
36. Diekema DJ, Richter SS, Heilmann KP, et al. Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: Results from a nationwide surveillance study. Infect Control Hosp Epidemiol 2014;35:285-292.
37. Cui L, Isii T, Fukuda M, et al. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2010;54:5222-5233.
38. Morales G, Picazo JJ, Baos E, et al. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 2010;50:821-825.
39. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997;24:914-919.
40. Marculescu CE, Berbari EF, Hanssen AD, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006;42:471-478.
41. Azzam KA, Seeley M, Ghanem E, et al. Irrigation and debridement in the management of prosthetic joint infection: Traditional indications revisited. J Arthroplasty 2010;25:1022-1027.
42. Barberán J, Aguilar L, Carroquino G, et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 2006;119:993-997.
43. Romanò CL, Manzi G, Logoluso N, Romanò D. Value of debridement and irrigation for the treatment of peri-prosthetic infections: a systematic review. Hip Int 2012;22(Suppl8):S19-S24.
44. Aboltins CA, Page MA, Buising KL, et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007;13:586-591.
45. Byren I, Bejon P, Atkins BL, et al. One hundred and twelve infected arthroplasties treated with "DAIR" (debridement, antibiotics and implant retention): Antibiotic duration and outcome. J Antimicrob Chemother 2009;63:1264-1271.
46. Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH. Periprosthetic infection due to resistant Staphylococci: Serious problems on the horizon. Clin Orthop Relat Res 2009;467:1732-1739.
47. Trebse R, Pisot V, Trampuz A. Treatment of infected retained implants. J Bone Joint Surg [Br] 2005;87-B:249-256.
48. Van Kleunen JP, Knox D, Garino JP, Lee G-C. Irrigation and débridement and prosthesis retention for treating acute periprosthetic infections. Clin Orthop Relat Res 2010;468:2024-2028.
49. Vilchez F, Martínez-Pastor JC, García-Ramiro S, et al. Efficacy of debridement in hematogenous and early post-surgical prosthetic joint infections. IJAO 2011;34:863-869.
50. Vilchez F, Martínez-Pastor JC, García-Ramiro S, et al. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011;17:439-444.
51. Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007;481:48-53.
52. Walls RJ, Roche SJ, O'Rourke A, McCabe JP. Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. J Bone Joint Surg [Br] 2008;90-B:292-298.
53. Bradbury T, Fehring TK, Taunton M, et al. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty 2009;24:101-104.
54. Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 2000;381:101-105.
55. Buchholz HW, Elson RA, Engelbrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg [Br] 1981;63-B:342-353.
56. Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg [Am] 1978;60-A:1059-1064.
57. Miley GB, Scheller AD, Turner RH. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res 1982;170:76-82.
58. Wroblewski BM. One-stage revision of infected cemented total hip arthroplasty. Clin Orthop Relat Res 1986;211:103-107.
59. Raut VV, Siney PD, Wroblewski BM. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg [Br] 1994;76-B:721-724.
60. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement: an average ten-year follow-up. J Bone Joint Surg [Am] 1998;80-A:961-968.
61. Drancourt M, Stein A, Argenson JN, et al. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemotherap 1993;37:1214-1218.
62. Raut VV, Orth MS, Orth MC, Siney PD, Wroblewski BM. One stage revision arthroplasty of the hip for deep gram negative infection. Int Orthop 1996;20:12-14.
63. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Long-term follow up. Clin Orthop Relat Res 1995;321:202-207.
64. Mulcahy DM, O'Byrne JM, Fenelon GE. One stage surgical management of deep infection of total hip arthroplasty. Ir J Med Sci 1996;165:17-19.
65. Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop Relat Res 1999;369:139-143.
66. Rudelli S, Uip D, Honda E, Lima A. One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty. 2008;23:1-13.
67. Yoo JJ, Kwon YS, Koo K-H, et al. One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop 2008;33:1195-1201.
68. Engesaeter LB, Dale H, Schrama JC, Hallan G, Lie SA. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop 2011;82:530-537.
69. Kim Y-H, Kim J-S, Park J-W, Joo J-H. Cementless revision for infected total hip replacements. J Bone Joint Surg [Br] 2011;93-B:19-26.
70. Biring G, Kostamo T, Garbuz DS, Masri BA, Duncan CP. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. J Bone Joint Surg [Br] 2009;91-B:1431-1437.
71. Oussedik SIS, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg [Br] 2010;92-B:1222-1226.
72. Takahira N, Itoman M, Higashi K, et al. Treatment outcome of two-stage revision total hip arthroplasty for infected hip arthroplasty using antibiotic-impregnated cement spacer. J Orthop Sci 2003;8:26-31.
73. Ekpo TE, Berend KR, Morris MJ, Adams JB, Lombardi AV. Partial two-stage exchange for infected total hip arthroplasty: A preliminary report. Clin Orthop Relat Res 2014;472:437-448.
74. Kilgus DJ, Howe DJ, Strang A. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 2002;404:116-124.
75. Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two-stage total hip arthroplasty: How often does It control methicillin-resistant infection? Clin Orthop Relat Res 2010;469:1009-1015.
76. Lim S-J, Park J-C, Moon Y-W, Park Y-S. Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol. J Arthroplasty 2009;24:1264-1269.
77. Volin SJ, Hinrichs SH, Garvin KL. Two-stage reimplantation of total joint infections: A comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 2004;427:94-100.
78. Murray TG, Cochran J, Klika AK, Krebs VE, Barsoum WK. Do resistant organisms affect success of two-stage reimplantation for prosthetic hip infections? Curr Orthop Pract 2011;22:180-184.
79. Mittal Y, Fehring TK, Hanssen A, et al. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg [Am] 2007;89-A:1227-1231.